Table 3 Weight gain, total food intake, serum inflammation and oxidative stress biomarkers and antioxidant enzyme activity in liver at the end of the treatment phase

Weight gain(g)

−22 ± 22^a

−22.8 ± 18.4^a

16.8 ± 7.8^b

12.3 ± 10.2^b

Food intake(g)

77.7 ± 5.1^a

82.1 ± 6.4^a

111.5 ± 16.8^b

102.7 ± 7.6^b

CCK(ng/l)

117.5 ± 48.9

116.4 ± 29.8

127.5 ± 23.1

133.8 ± 17.5

Hs_CRP(ng/ml)

3.48 ± 0.62^a

3.68 ± 0.43^a

4.69 ± 0.96^b

3.68 ± 0.64^a

PTX-3(ng/ml)

0.63 ± 0.14^a

0.63 ± 0.09^a

0.86 ± 0.1^b

0.67 ± 0.17^a

MMP-9(ng/ml)

0.5 ± 0.09^a

0.52 ± 0.19^a

0.81 ± 0.22^b

0.64 ± 0.17^ab

TAC(μmol/l)

214(181.5–219.2)^ab

204(199–216.5)^a

186(180.5–191.2)^b

209(205.5–212)^a

GPX(U/ml)

233.8 ± 33.5^a

365.9 ± 115.7^b

224.6 ± 51.7^a

336.1 ± 86.1^b

SOD(U/ml)

56 ± 25.5

59.9 ± 14.2

44.4 ± 14.6

70.7 ± 16.1

Steatosis score

0(0–0.25)^a

0(0–0)^a

2(1–2)^b

1(0–1)^a

NAS score

1(0–2)^a

1(0–2)^a

4(3–5)^b

2(0–4)^ab